GERN Stock Price
Geron Corporation
$1.19
-$0.01(-0.83%)
40
Overall
60
Value
18
Tech
42
Quality
Market Cap
$764.54M
Volume
5.42M
52W Range
$1.04 - $2.01
Target Price
$3.60
GERN stock price is $1.19 (-0.83% on the day), giving Geron Corporation a market cap of $764.54M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
GERN Stock Overview
- Price
- $1.19
- Previous close
- $1.20
- Open
- $1.20
- Market cap
- $764.54M
- P/E ratio
- -9.2
- 52-week range
- $1.04 - $2.01
- 1-year price target
- $3.60
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 40
About Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GERN | $1.19 | -0.8% | 5.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |